Posts Tagged ‘aggressiveness’

Judge Agrees Prozac Turned Teen into Murderer

Monday, October 3rd, 2011

Antidepressant Caused a Stimulant-like Syndrome Leading to Manic-like Behavior, Suicidality and Violence

PR Newswire—October 3, 2011

Judge Robert Heinrich listened to expert psychiatric testimony for the defense by Peter Breggin, MD and issued his opinion regarding the sixteen-year-old who stabbed his friend to death.

The judge stated, “His basic normalcy now further confirms he no longer poses a risk of violence to anyone and that his mental deterioration and resulting violence would not have taken place without exposure to Prozac.” Consistent with Dr. Breggin’s testimony, the judge observed, “He has none of the characteristics of a perpetrator of violence. The prospects for rehabilitation are good.”

This is the first criminal case in North America where a judge has specifically found that an antidepressant was the cause of a murder.

The case involved a high school student with no violence who abruptly stabbed one of his friends to death at home with a single wound to the chest. The boy had been taking Prozac for three months, during which his behavior deteriorated.

Starting approximately 2005 to the present, the FDA required official drug labels to include information about dangers under the section titled WARNINGS-Clinical Worsening and Suicide Risk. The list of adverse effects—”anxiety, agitation, panic attacks,insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, and mania”—is a prescription for violence. Canadian drug regulatory agency,  Health Canada, also warns about these side effects.

Dr. Breggin testified the boy’s symptoms were consistent with a Prozac (fluoxetine) Induced Mood Disorder with Manic Features and he would not have committed the violence if he had not been given the antidepressant. He brought numerous independent scientific studies to court confirming his testimony.

The hearing determined whether or not the now 17 year old should be sentenced as a minor, limiting jail time. The prosecution wanted him tried as an adult. On October 4, 2011 final sentencing will occur. The judge’s decision represents an enormous step forward in recognizing the newer antidepressants can cause violence.

« Return to news items


Share

Psychiatric drug use skyrockets in U.S. military

Monday, July 26th, 2010

Natural News
By David Gutierrez
July 26, 2010

Use of prescription psychotropics has skyrocketed among U.S. military personnel in recent years, according to an investigation by Military Times.

At least 17 percent of active-duty military personnel are currently taking an antidepressant, including as many as 6 percent of all deployed troops. In contrast, the rate of antidepressant use in the wider U.S. public is only 10 percent.

Overall, one in six military service members takes at least one type of psychiatric drug. The numbers are probably higher than estimated, since troops are also known to share and trade prescription drugs with each other, even while in combat zones.

Data obtained from the Defense Logistics Agency show that overall use of psychiatric drugs increased by 76 percent between 2001 and 2009. More specifically, use of anti-seizure drugs increased 70 percent, use of sedatives and anxiety drugs increased 170 percent, and antipsychotic use increased 200 percent.

Spending on anticonvulsants increased from $16 million to $35 million per year, spending on anxiety drugs and sedatives increased from $6 million to $17 million, and spending on antipsychotics increased from $4 million to $16 million.

Although antidepressants are among the drugs most commonly taken by military personnel, their use increased only 40 percent between 2001 and 2009. Spending actually dropped by 16 percent, likely reflecting the new availability of less-expensive generic drugs.

According to a 2009 study by the Veterans Affairs Administration, approximately 60 percent of psychiatric drug use by military personnel is for “off-label” uses not approved by the FDA. Thus, antipsychotic drugs intended for the treatment of schizophrenia are now being widely prescribed for post-traumatic stress disorder symptoms such as anger, headaches, nervousness and nightmares.

“Patients may be exposed to drugs that have problematic side effects without deriving any benefit,” said Robert Rosenheck of Yale University. “We just don’t know. There haven’t been very many studies.”

Further compounding concern over side effects, many troops regularly mix two or more drugs together into untested cocktails. The effects of multiple drugs acting in unison have rarely been tested. When both drugs act on the same organ — in this case, the brain — the chance of unforeseen interactions is even greater.

“In the case of poly-drug use — the ‘cocktail’ — where you are combining an antidepressant, an anticonvulsant, an antipsychotic, and maybe a stimulant to keep this guy awake — that has never been tested,” Breggin said.

Among the side effects that some health professionals worry about are impaired motor skills, reduced reaction time, increased suicide risk, irritability, aggressiveness and hostility.

“Imagine causing that in men and women who are heavily armed and under a great deal of stress,” psychiatrist Peter Breggin said.

Read entire article:  http://www.naturalnews.com/029285_psychiatric_drugs_military.html

« Return to news items


Share

SSRIs Render Unfriendly Skies—FOIA documents reveal what FAA failed to consider in allowing pilots on antidepressants to fly

Wednesday, July 14th, 2010

Scoop Independent News
By Evelyn Pringle
July 14, 2010

The SSRI antidepressant makers are desperate to find new customers, so they recently have been focusing on capturing groups for which the drugs were usually considered off limits. The latest marketing coup managed to open up sales to roughly 614,000 American pilots.

Under a new policy announced on April 5, 2010, pilots diagnosed with depression can seek permission from the Federal Aviation Administration to take one of four SSRIs, including Eli Lilly’s Prozac, Pfizer’s Zoloft, and Forest Laboratories’ Celexa and Lexapro.

“The FAA should reverse its ruling before it’s too late and hundreds of lives are lost when a pilot becomes impulsive, suicidal or violent–or just loses his sharpness–under the influence of antidepressant medication,” said SSRI expert, Dr Peter Breggin, in an April 19, 2010 Huffington Post commentary.

The Citizens Commission on Human Rights is also calling on the FAA to rethink allowing pilots to take SSRI in light of a new report issued last month by the National Transportation Safety Board, on a February 1, 2008 plane crash in North Carolina, by a crazy acting pilot on Zoloft, that killed all six persons on board

The report said the pilot failed to maintain control of the plane during instrument flying conditions and “deliberately descended below the minimum descent altitude.” The plane stalled and crashed while circling after an aborted landing.

“Review of the cockpit voice recorder (CVR) audio revealed that the pilot had displayed some non-professional behavior before initiating the approach,” the NTSB reported.

The CVR recorded the pilot singing: “Save my life I’m going down for the last time,” before beginning a commentary in which he told passengers: “If anybody back there believes in the good Lord, I believe now would be a good time to hit your knees.”

A review of medical records documented that “from December 4, 2006 through December 31, 2007, the pilot had filled 6 prescriptions for 30 tablets of 50 mg sertraline (Zoloft),” the report said.

The records indicated that he had been treated previously with two other antidepressant medications for “anxiety and depression” and a history of “impatience” and “compulsiveness,” the NTSB noted.

An investigation of another plane crash, resulting in two fatalities in Kingsport, Tennessee, in August 2003, found Zoloft in the blood and liver of a private flight instructor, according to an accident report by the NTSB.

In the policy statement published in the Federal Register, the FAA seems to justify the use of these drugs via the fully debunked “chemical imbalance in the brain” theory when writing: “All these medications are SSRIs, antidepressants that help restore the balance of serotonin, a naturally occurring chemical substance found in the brain.”

“Increasingly accepted and prevalently used, these four antidepressants may be used safely in appropriate cases with proper oversight and have fewer side effects than previous generations of antidepressants,” the FAA wrote, with no citation to any scientific paper to back up this assertion.

In fact, the current labels on SSRIs warn that “anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, and mania, have been reported in adult and pediatric patients treated for major depressive disorder as well as for other indications, both psychiatric and nonpsychiatric.”

“Even when not severe, these reactions impair judgment and increase the likelihood of accidents and violence,” according to Dr Breggin.

CCHR has set up a great website with a one-of-a-kind search engine that allows the public and officials to access the database on side effects reported to the FDA on SSRIs, and every other psychiatric drug. The site also has a search engine to access all the International warnings and studies on psychiatric drugs which have been summarized so they are easy to understand, even to a lay person.

Input Only From the Choir

On April 6, 2010, Bob Fiddaman, author of the long-running popular website and blog, “Seroxat Sufferers,” sent a request to the FAA, under the Freedom of Information Act, seeking information on the change in policy.

In the Federal Register, the FAA claims it came to its decision after “careful consideration.” However, in the 58 pages of documents sent to Fiddaman on June 9, 2010 (and kindly shared with this author), there is no mention of consultations with any of the prominent SSRI experts who may have offered a contrary view. Like Peter Breggin for instance.

The FAA’s response to Fiddaman shows the agency has been discussing the policy change since at least 2008. In response to a request for “minutes of meetings where the change in the policy was on the agenda,” as well as a list of “members present and a declaration of interests of each of the members,” the FAA sent a copy of a July 18, 2008, Memorandum, with a summary from one consultants meeting. Three outside experts attended but there were no declarations of interests, or lack thereof, by anyone at the meeting.

The summary noted that the consultants “unanimously agreed that the concept of allowing certain airmen taking antidepressant medication was reasonable and safe.” But the “unanimous consensus” was that only Prozac and Zoloft “were appropriate medications due to the longevity of their use and overall safety.”

“They also felt that only these two should be considered initially, and no other medications considered at this time,” the summary reported.

In responding to the question of whether the new policy would apply to Air Traffic Controllers, the FAA said the “new policy does not presently apply to Air Traffic Control Specialist (ATCS) because the administrative details of the monitoring and follow-up of these employees are yet to be determined. The plan is that ATCSs will eventually be included in a program of this type.”

In response to a request for any information “given to FAA from outside parties that relate to the FAA’S recent change in policy regarding pilots on antidepressant medication,” the FAA sent copies of documents received from the Aerospace Medical Association, the Airline Pilots Association Aeromedical Office, the International Airline Pilots Association, and the United States Army.

“In developing the new policy, the FAA also utilized a variety of medical research literature available in the public domain,” the response said. “We used internet sites such as, but not limited to: The National Library of Medicine PubMed site and the FDA Medwatch.”

The documents Fiddaman received show consideration of a 2003 study of aviation accidents that found SSRIs in 61 pilot fatalities between 1990-2001, in which the psychological condition and/or the drug use was determined to be the cause, or a factor in 16 of the accidents, or 31%.

However, there was no mention of a later November 2006 study titled, “Pilot Medical History and Medications Found in Post Mortem Specimens for Aviation Accidents,” led by Dennis Canfield, from the FAA’s Civil Aerospace Medical Institute, in the “Aviation, Space, and Environmental Medicine” journal.

For this study, toxicological evaluations were performed on 4,143 pilots involved in fatal aviation accidents during the period between January 1, 1993, through December 31, 2003, to identify all pilots found positive for medications used to treat cardiovascular, psychological, or neurological conditions.

The evaluations found one-hundred dead pilots with SSRIs in their systems including forty with Prozac, twenty-six with Zoloft, twenty-one with Paxil, and thirteen with Celexa.

Less than a month after the new policy was announced, in “Aviation International News,” on May 1, 2010, Matt Thurber reported that in a review of 127 accidents in the NTSB database since 1991, containing the word “antidepressant,” only three were nonfatal.

“In 124 of those accidents, 211 people were killed,” Thurber said. “In accident after accident, antidepressants … were found in the tissues of dead pilots, and the pilots had falsified their medical certificate applications to show that they had never been treated for psychiatric problems.”

Read the rest of this article here:  http://www.scoop.co.nz/stories/HL1007/S00116.htm

Read FOIA documents here: http://fiddaman.blogspot.com/p/faa-respond-to-freedom-of-information.html

« Return to news items


Share

Hidden Facts About Ritalin; Side Effects include brain damage, psychosis, severe dependence, paranoia

Monday, July 5th, 2010

New With Views
By Jon Rappoport
July 5, 2010

In 1986, The International Journal of the Addictions published a very important literature review by Richard Scarnati. It was called “An Outline of Hazardous Side Effects of Ritalin (Methylphenidate)” [v.21(7), pp. 837-841].

Scarnati listed a large number of adverse affects of Ritalin and cited published journal articles which reported each of these symptoms.

For every one of the following Ritalin effects, there is at least one confirming source in the medical literature:

• Paranoid delusions
• Paranoid psychosis
• Hypomanic and manic symptoms, amphetamine-like psychosis
• Activation of psychotic symptoms
• Toxic psychosis
• Visual hallucinations
• Auditory hallucinations
• Can surpass LSD in producing bizarre experiences
• Effects pathological thought processes
• Extreme withdrawal
• Terrified affect
• Started screaming
• Aggressiveness
• Insomnia
• Since Ritalin is considered an amphetamine-type drug, expect amphetamine-like effects
• Psychic dependence
• High-abuse potential DEA Schedule II Drug
• Decreased REM sleep
• When used with antidepressants one may see dangerous reactions including hypertension, seizures and hypothermia
• Convulsions
• Brain damage may be seen with amphetamine abuse.

Many parents around the country have discovered that Ritalin has become a condition for their children continuing in school. There are even reports, by parents, of threats from social agencies: “If you don’t allow us to prescribe Ritalin for your ADHD child, we may decide that you are an unfit parent. We may decide to take your child away.”

This mind-boggling state of affairs is fueled by teachers, principals, and school counselors, none of whom have medical training. Yet even if they did…

The very existence of the “illnesses” for which Ritalin would be prescribed is unproven. It is merely assumed.

In commenting on Dr. Lawrence Diller’s book, Running on Ritalin, Dr. William Carey, Director of Behavioral Pediatrics, Children’s Hospital of Philadelphia, has written, “Dr. Diller has correctly described… the disturbing trend of blaming children’s social, behavioral, and academic performance problems entirely on an unproven brain deficit…”

On November 16-18, 1998, the National Institute of Mental Health held the prestigious “NIH Consensus Development Conference on Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder [ADHD].” The conference was explicitly aimed at ending all debate about the diagnoses of ADD, ADHD, and about the prescription of Ritalin. It was hoped that at the highest levels of medical research and bureaucracy, a clear position would be taken: this is what ADHD is, this is where it comes from, and these are the drugs it should be treated with. That didn’t happen, amazingly. Instead, the official panel responsible for drawing conclusions from the conference threw cold water on the whole attempt to reach a comfortable consensus.

Read entire article:  http://www.newswithviews.com/Rappoport/jon101.htm

« Return to news items


Share

The FAA will Allow Antidepressant Popping Pilots and their Lethal Side Effects in an Unfriendly Sky

Monday, April 5th, 2010

PR-inside.com
April 5, 2010

Ever wonder, which government agency would be most likely to put a person in harms way. If you join the military then you volunteer to be placed in the line of fire if under enemy attack. The antidepressant use can also kill you on the base just like it did at Ft. Hood several months ago. The IRS will use fear instead of mortality, but they can certainly incarcerate you which could be a slow death. The FDA has been approving psychotropic drugs, heart medications, birth control pills et al, with horrendous track records and mortal consequences since its inception. Some of those drugs have been taken off the market, but most like antidepressants are still available even though it is widely known they depress patients. Now we have the latest US government agency the FAA, which will now allow pilots to medicate and fly.

Some of the side effects of these now allowable medications (Prozac, Zoloft, Celexa, Lexapro) are suicide, mania, agitation, dizziness, fatigue, insomnia, tremors, muscle aches, diarrhea, fast heartbeat, fever chills, fainting, bizarre behavior, aggressiveness, joint or wrist aches and pain, ringing in the ears, confusion, decreased concentration, decreased coordination, exaggerated feeling of well being, irritability, hostility, memory loss, vomiting, mood changes, unusual weakness, vision changes, hallucinations, and worsening of depression. Do you feel safe to fly in a tin can at 35,000 feet when the pilot may have one or more of these side effects? It seems clear the FAA is looking at only one head in the head count. Based on these side effects you could have a maniac flying the plane! You should get thrown off the plane for bizarre behavior, but today you get to be the captain.

Read entire article:  http://www.pr-inside.com/the-faa-will-allow-antidepressant-popping-r1813445.htm

Click here for a related video:  http://www.newsy.com/videos/pilots-on-antidepressants-permitted-to-fly

« Return to news items


Share